Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Cancer stem cell

  • Open Access
    Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents
    KUMIKO MIYASHITA, KIMIHIRO YAMASHITA, MAKOTO MIYOSHI, TAKAAKI NISHIYAMA, YUKI ISE, SHUN OHSAKA, KAZUYA SHIMIZU, NORIYUKI NISHIMURA and YUICHI HORI
    Anticancer Research April 2026, 46 (4) 1819-1831; DOI: https://doi.org/10.21873/anticanres.18076
  • You have access
    Homochlorcyclizine Dihydrochloride Inhibits Hepatocellular Carcinoma Progression and Cancer Stem Cell Properties
    JIAYI WU, XINZHU FU, SHIYUAN CHANG and WEIJUN SU
    Anticancer Research December 2025, 45 (12) 5465-5475; DOI: https://doi.org/10.21873/anticanres.17882
  • Open Access
    Cancer Stem Cells in Glioblastoma: The Role of the mTOR Pathway
    MONICA C. MUREB, SABRINA L. ZELLER, HAYLEN T. ROSBERGER, ERIS SPIROLLARI, MOHAN DAS, SIMON J. HANFT, CHIRAG D. GANDHI and MEENA JHANWAR-UNIYAL
    Anticancer Research July 2025, 45 (7) 2697-2709; DOI: https://doi.org/10.21873/anticanres.17640
  • Open Access
    Resveratrol Can Differentiate Human Melanoma Stem-like Cells from Spheroids Treated With All-trans Retinoic Acid
    MINA KANAI, AKIHO SHINAGAWA, MASAKO OTA, NANTIGA VIRGONA and TOMOHIRO YANO
    Anticancer Research December 2024, 44 (12) 5283-5292; DOI: https://doi.org/10.21873/anticanres.17356
  • Open Access
    Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board
    SANT P. CHAWLA, BRIAN VAN TINE, NOAH FEDERMAN, JOSEPH SCHWAB, ROBIN JONES, VIVEK SUBBIAH, NEAL S. CHAWLA, NIMA AFSHAR, WILLY HOOS, NANCY FELDMAN, H. TRENT SPENCER, WILLIAM SWANEY and ERLINDA M. GORDON
    Anticancer Research July 2024, 44 (7) 2765-2768; DOI: https://doi.org/10.21873/anticanres.17139
  • You have access
    Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1
    TOMOHIDE SHIROSAKI, NORIKO KAWAI, YUMA EBIHARA, AIKO MURAI, TERUFUMI KUBO, RENA MORITA, KENJI MURATA, TAKAYUKI KANASEKI, TOMOHIDE TSUKAHARA, TOSHIAKI SHICHINOHE, YOSHIHIKO HIROHASHI, SATOSHI HIRANO and TOSHIHIKO TORIGOE
    Anticancer Research May 2024, 44 (5) 1877-1883; DOI: https://doi.org/10.21873/anticanres.16989
  • You have access
    BBT-877, a Novel Autotaxin Inhibitor, Abrogates Drug Resistance in Epithelial Ovarian Cancer Stem Cells
    JUN SE KIM, MIN JOO SHIN, SEO YUL LEE, SEONG MIN CHOI, KYUNG-UN CHOI, DONG-SOO SUH, DAE KYOUNG KIM and JAE HO KIM
    Anticancer Research March 2024, 44 (3) 1131-1142; DOI: https://doi.org/10.21873/anticanres.16908
  • Open Access
    Luminal B Breast Cancer Coexpressing p62 and ALDH1A3 Is Less Susceptible to Radiotherapy
    AYAKA OZAKI, AKARI MATSUDA, YUKI MAEMURA, YUNA TADA, TAKAHIRO KASAI, YUKA NAGASHIMA, CHOTARO ONAGA, YASUSHI HARA, KAZUKI KITABATAKE, MITSUTOSHI TSUKIMOTO, SHOMA TAMORI, KAZUNORI SASAKI, SHIGEO OHNO and KAZUNORI AKIMOTO
    Anticancer Research January 2024, 44 (1) 37-47; DOI: https://doi.org/10.21873/anticanres.16786
  • Open Access
    Cancer Stem Cells of Hepatocellular Carcinoma Are Suppressed by the Voltage-gated Calcium Channel Inhibitor Amlodipine
    ATSUSHI SHIOZAKI, KENTO KURASHIMA, MICHIHIRO KUDOU, HIROKI SHIMIZU, TOSHIYUKI KOSUGA, KENICHI TAKEMOTO, TOMOHIRO ARITA, HIROTAKA KONISHI, YUSUKE YAMAMOTO, RYO MORIMURA, SHUHEI KOMATSU, HISASHI IKOMA, TAKESHI KUBOTA, HITOSHI FUJIWARA and EIGO OTSUJI
    Anticancer Research November 2023, 43 (11) 4855-4864; DOI: https://doi.org/10.21873/anticanres.16682
  • Open Access
    High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer
    YUYUN XIONG, HITOMI MOTOMURA, SHOMA TAMORI, AYAKA OZAKI, CHOTARO ONAGA, YASUSHI HARA, KEIKO SATO, KOUJI TAHATA, YOHSUKE HARADA, KAZUNORI SASAKI, YUN-WEN ZHENG, SHIGEO OHNO and KAZUNORI AKIMOTO
    Anticancer Research November 2022, 42 (11) 5223-5232; DOI: https://doi.org/10.21873/anticanres.16029

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire